News | Cardiovascular Ultrasound | July 20, 2016

Study finds torsion of the heart visualized via ultrasound can help with patient selection

mitral valve surgery outcomes, twisting of the heart, echocardiography, NICSMR, JACC Basic to Translational Science

July 20, 2016 — A novel study has found a simple pre-operative echocardiographic measurement of the amount of torsion of the heart predicted outcomes of mitral valve surgery in some heart failure patients. The study was published in JACC: Basic to Translational Science.

The selection of appropriate candidates for mitral surgery among symptomatic patients with nonischemic, chronic secondary severe mitral regurgitation (NICSMR) can be challenging. This study demonstrates that assessment of left ventricular torsion — a twisting motion — may be useful for the prediction of post-mitral surgery outcomes in some patients.

Researchers examined 50 consecutive symptomatic NICSMR patients for a median follow-up of 2.5 years after mitral surgery. All patients had advanced heart failure symptoms and had already received the maximum guideline-directed medical therapy for more than six months. Baseline left ventricular size, shape and mass tended to be larger and more spherical in those who died, but not significantly so, while left ventricular torsion was higher in survivors. Patients were divided into three groups: preserved left ventricular torsion, lost left ventricular torsion, or patients with a wide QRS measurement who received cardiac resynchronization therapy. 

Patients received either mitral valve repair or mitral valve replacement. Two years after surgery, 19 patients had died. Researchers determined that in patients with NICSMR and a narrow QRS width, preserved left ventricular torsion may be a better predictor of post-mitral surgery survival, while conversely, lost left ventricular torsion may lead to a poor post-surgical outcome. The post-surgical survival results were intermediate in patients with a wide QRS. Patients who received cardiac resynchronization therapy prior to mitral surgery showed significantly worse two-year survival than those who received the procedure during mitral surgery. However, the two groups had similar left ventricular torsion.

“These findings show that lost left ventricular torsion and previously administered cardiac resynchronization therapy appear to be markers of poor survival after mitral surgery in patients with NICSMR,” said Yuichi Notomi, M.D., from the division of cardiovascular imaging, department of cardiology at The Hayama Heart Center in Kanagawa, Japan, and the lead author of the study. “We also found that reverse remodeling was only observed in patients with preserved left ventricular torsion, demonstrating that lost left ventricular torsion and wide QRS were markers of no reverse remodeling viability.” 

This study demonstrates that for patients with left-ventricular torsion and a narrow QRS measurement, mitral surgery is an acceptable option and that left ventricular torsion can help to predict post-mitral surgery outcomes in patients with a narrow QRS but not in those with a wide QRS.

“Mechanistically, this study suggests that the loss of torsion in patients with heart failure may reflect irreversible structural damage to the heart which would prevent the heart from recovering after corrective surgery,” said Douglas L. Mann, M.D., FACC, editor-in-chief of JACC: Basic to Translational Science. “If correct, this will have much broader implications than improvement after mitral valve surgery since it may predict which patients with heart failure may get better on medications.” 

Mann added that these findings will need confirmation as the analysis was retrospective and took place in a small number of patients. 

For more information: www.basictranslational.onlinejacc.org


Related Content

News | Ultrasound Women's Health

Feb. 5, 2026 — BrightHeart, a global provider of AI-driven prenatal ultrasound, has announced the availability of its B ...

Time February 05, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Jan. 27, 2026 — Hyperfine has announced results from the largest data set to date evaluating stroke detection with its ...

Time January 28, 2026
arrow
News | Radiology Education

Jan. 22, 2026—The American Roentgen Ray Society (ARRS) will host a live virtual symposium, "Medical Imaging for ...

Time January 28, 2026
arrow
News | Point-of-Care Ultrasound (POCUS)

Jan. 27, 2026 — Siemens Healthineers and World Athletics have joined forces to inform medical teams how point-of-care ...

Time January 27, 2026
arrow
News | PET Imaging

Jan. 26, 2026 — Nuclidium, a clinical-stage radiopharmaceutical company developing a proprietary copper-based ...

Time January 27, 2026
arrow
News | Radiology Imaging

Jan. 26, 2026 — Researchers at the University of Arizona were awarded up to $1.8 million by the Advanced Research ...

Time January 26, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Jan. 20, 2026 — Hyperfine, the developer of the first FDA-cleared AI-powered portable MRI system for the brain — the ...

Time January 20, 2026
arrow
News | Focused Ultrasound Therapy

Dec. 19, 2025 — Washington University in St. Louis (WashU) has been recognized as a Focused Ultrasound Center of ...

Time December 23, 2025
arrow
News | Cardiac Imaging

Dec. 15, 2025 — Royal Philips has entered into an agreement to acquire SpectraWAVE, Inc., an innovator in enhanced ...

Time December 18, 2025
arrow
News | RSNA 2025

Oct. 31, 2025 — Echolight plans to demonstrate its bone density scanning technology at the Radiological Society of North ...

Time November 03, 2025
arrow
Subscribe Now